Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression

Journal of Infectious Diseases

Volumn 180, Issue 4, 1999, Pages 1106-1115

  De Roda Husman, Ana Maria ^a   Van Rij, Ronald P ^a   Blaak, Hetty ^a   Broersen, Silvia ^a   Schuitemaker, Hanneke ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; SYNCYTIUM; VIRUS LOAD; VIRUS REPLICATION;

ANTIGENS, CD4; CELL LINE; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GENOTYPE; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; LONGITUDINAL STUDIES; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4; RECEPTORS, CYTOKINE; SURVIVORS; T-LYMPHOCYTES; TIME FACTORS; TRANSFECTION; VARIATION (GENETICS); VIRAL LOAD;

EID: 0033383722     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314987     Document Type: Article

References (50)

1. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor functional cDNA cloning of a seven-transmembrane, O protein-coupled receptor. Science 1996; 272:872-7.
2. Simmons G, Wilkinson D, Reeves JD, et al. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use cither LESTR or CCR5 as co-receptors for virus entry. J Virol 1996; 70:8355-60.
3. Zhang L, Huang Y, He T, Cao Y, Ho DD. HIV-1 subtype and second-receptor use. Nature 1996; 383-768.
4. Björndal A, Deng H, Jansson M, et al. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 1997; 71:7478-87.
5. Scarlatti G, Trusoldi E, Björndal A, et al. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine mediated suppression. Nature Medicine 1997; 3:1259-65.
6. Doranz BJ, Ruckcr J, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3 and CKR-2b as fusion cofactors. Cell 1996; 85:1149-58.
7. Deng HK, Liu R, Ellmeier W, et al. Identification of the major co-receptor for primary isolates of HIV-1. Nature 1996; 381:661-6.
8. Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4 cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381:667-73.
9. Alkhatib G, Combadiere C, Broder CC, et al. CC CR5; A RANTES, MIP-α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996; 272:1955-8.
10. Choe H, Farzan M, Sun Y, et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996; 85:1135-48.
11. Schuitemaker H, Kootstra NA, De Gnede REY, De Wolf F, Miedema F, Tersmette M. Monocytotropic human immunodeficiency virus 1 (HIV-1) variants detectable in all stages of HIV infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J Virol 1991; 65:356-63.
12. Schuitemaker H, Kool M, Kootstra NA, et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 1992; 66:1354-60.
13. Zhu T, Mo H, Wang N, et al. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993; 261:1179-81.
14. Connor RI, Mohri H, Cao Y, Ho DD. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in humun immunodeficiency virus type 1 infected individuals. J Virol 1993; 67:1772-7.
15. Roos MThL, Lange JMA, De Goede REY, et al. Viral phenotype and immune response in primary human immunodeficiency virus type 1 (HIV-1) infection. J Infect Dis 1992; 165:427-32.
16. Van 't Wout AB, Kootstra NA, Mulder-Kampinga GA. et al. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral and vertical transmission. J Clin Invest 1994; 94:2060-7.
17. Blaak H, Van 't Wout AB, Brouwer M. et al. Infectious cellular load in HIV-1 infected individuals and susceptibility of PBMC from their exposed partners to NSI HIV-1 as major determinants for HIV-1 transmission in homosexual couples. J Virol 1998; 72:218-24.
18. Blaak H, Brouwer M, Ran LJ, De Wolf F, Schuitemaker H. In vitro replication kinetics of HIV-1 variants in relation to viral load in long-term survivors of HIV-1 infection. J Infect Dis 1998; 177:600-10.
19. Tersmette M, Gruters RA, De Wolf F, et al. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J Virol 1989; 63:2118-25.
20. + cell depletion and progression to AIDS. Ann Intern Med 1993; 118:681-8.
21. Bozzette SA, McCutchan JA, Spector SA, Wright B, Richman DD. A cross-sectional comparison of persons with syncytium- and non-syncytium inducing human immunodeficiency virus. J Infect Dis 1993; 168:1374-9.
22. Connor RI, Sheridan KE, Ceradini D, Choc S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997; 185:621-8.
23. Xiao L, Rudolph DL, Owen SM, Spira TJ, Lal RB. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression. AIDS 1998; 12:F137-43.
24. De Roda Husman AM, Koot M, Cornelissen M. et al Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Intern Med 1997; 127:882-90.
25. van Rij RP, De Roda Husman AM, Brouwer M, Goudsmit J, Coutinho RA, Schuitemaker H. Role of CCR2 genotype in the clinical course of syncytium-inducing or non-syncytium inducing HIV-1 infection and in the conversion rate towards S1 virus variants. J Infect Dis 1998; 178:1806-11.
26. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression lo AIDS by a deletion allele of the CKR5 structural gene. Science 1996; 273:1856-62.
27. Smith MW, Dean M, Carrington M, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997; 277:959-65.
28. Kostrikis LG, Huang V, Moore JP, et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with it CCR5 promotor mutation. Nat Med 1998; 4:350-3.
29. Rizzardi GP, Morawetz RA, Vicenzi E, et al. CCR2 polymorphism and HIV disease. Nat Med 1998; 4:252-3.
30. Klein MR, Miedema F. Long-term survivors of HIV-1 infection. Trends Microbiol 1995; 3:386-391.
31. Jurriaans S, van Gemen B, Weverling GJ. et al. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? Virology 1994; 204:223-33.
32. De Wolf F, Spijkerman I, Schellekens PThA, et al. AIDS prognosis based on HIV-1 RNA, CD4+ T cell count and function: Markers with reciprocal predictive value over time after seroconversion. AIDS 1997; 11:1799-1806.
33. Tersmette M, Winkel TN, Groenink M, et al. Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV-p24gag. Virology 1989; 171:149-55.
34. Koot M, Vos AHV, Keet RPM, et al, HIV-1 biological phenotype in long term infected individuals, evaluated with an MT-2 cocultivation assay. AIDS 1992; 6:49-54.
35. He J, Chen Y, Farzan M, et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 1997; 385:645-9.
36. Heath H, Qin S, Rao P, et al. Chemokine receptor usage by eosinophils. The importance of CCR3 showed by using an antagonistic monoclonal antibody. J Clin Invest 1997; 99:178-84.
37. Jolly DJ, Okayama H, Berg P, et al. Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyltransferase. Proc Natl Acad Sci USA 1983; 80:477-81.
38. Koot M, Van Leeuwen R, De Goede RFY, et al. Conversion rate towards a syncytium inducing (SI) phenotype during different stages of HIV-1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis. J Infect Dis 1998; 179:254-8.
39. Wu L, Paxton WA, Kassam N, et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997; 185:1081-91.
40. Samson M, Stordeur P, Labbe O, Soularue P, Vassart O, Parmentier M. Molecular cloning and chromosomal mapping of a novel human gene, ChemRI, expressed in T lymphocytes and polymorphonuclear cell and encoding a putative chemokine receptor. Eur J Immunol 1996; 26:302-18.
41. Stuber Roos R, Loetscher M, Legler DF, dark-Lewis I, Baggiolini M, Moser B. Identification of CCR8, the receptor for the human CC chemokine I-309. J Biol Chem 1997; 272:17251-4.
42. Fdingur AL, Huffman TL, Sharron M, Lee B, O'Dowd R, Doms RW Use of GPR1, GPR15, and STRL33 us coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins. Virology 1998; 249:367-78.
43. Farzan M, Choe H, Martin K, et al. Two orphan seven-transmembrane segment receptors which arc expressed in CD4-positive cells support simian immunodeficiency virus infection. J Exp Med 1997; 186:405-11.
44. Rucker J, Edinger AL, Sharron M, et al. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J Virol 1997; 71:8999-9007.
45. Liao F, Alkhatib G, Peden KWC, Sharma G, Berger EA, Farber JM. STRL33, a novel chemokine receptor-like protein, functions as fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med 1997; 85:2015-23.
46. Deng HK, Unutmaz D, KewalRamani VN, Littman DR. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997; 388:296-300.
47. Edinger AL, Hoffman TL, Sharron M, et al. An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a co-receptior for human immunodeficiency virus type 1 and simian immunodeficiency virus. J Virol 1998; 72:7934-40.
48. Owman C, Garzino-Demo A, Cocchi F, Popovic M, Sabirsh A, Gallo RC. The leucotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells. Proc Natl Acad Sci USA 1998; 95:9530-4.
49. Choe H, Farzan M, Konkel M, et al. The orphan seven-transmembrane receptor Apj supports the entry of primary T-cell-line-tropic and dual-tropic human immunodeficiency virus type 1. J Virol 1998; 72:6113-8.
50. Tscherning C, Alacus A, Frederiksson R, et al. Differences in chemokine receptor usage between genetic subtypes of HIV-1. Virology 1998; 241:181-8.